U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Apr-11-2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | DENCO | |
Apr-11-2023 | DEATH OF INTERNATIONAL REGISTRATION | DETHP | |
Sep-27-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Sep-09-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Sep-09-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
Aug-22-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jul-23-2019 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
May-07-2019 | PUBLISHED FOR OPPOSITION | PUBOA | |
Apr-17-2019 | NOTICE OF PUBLICATION | NPUBO | |
Mar-27-2019 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Mar-26-2019 | ASSIGNED TO EXAMINER | DOCKD | |
Mar-22-2019 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Mar-18-2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Mar-15-2019 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Mar-14-2019 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM |